Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03193281
Title KISS Study: Kinase Inhibition With Sprycel Start up (KISS)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Auckland, New Zealand
Indications

chronic myeloid leukemia

Therapies

Imatinib

Dasatinib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.